1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [f5340331-b6b4-4639-960f-1b9f4c135136] => Array ( [runtime-id] => f5340331-b6b4-4639-960f-1b9f4c135136 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [9eff98ec-05d1-422c-aa22-6946d8496c9f] => Array ( [runtime-id] => 9eff98ec-05d1-422c-aa22-6946d8496c9f [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;6c6474883ad043ec09aea804b308fbab8ad92ad0 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [f5340331-b6b4-4639-960f-1b9f4c135136] => Array ( [runtime-id] => f5340331-b6b4-4639-960f-1b9f4c135136 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [9eff98ec-05d1-422c-aa22-6946d8496c9f] => Array ( [runtime-id] => 9eff98ec-05d1-422c-aa22-6946d8496c9f [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;6c6474883ad043ec09aea804b308fbab8ad92ad0 ) ) )Table 1:Univariate association between PET/MR imaging NI-RADS and treatment failure
PET/MR Imaging NI-RADS Score No. Sites Failure P Value Primary site 43 18 (41.9%) <.001 1 19 2 (10.5%) 2 12 5 (41.7%) 3 12 11 (91.7%) Neck lymph nodes 43 5 (11.6%) <.001 1 33 0 (0.0%) 2 6 1 (16.7%) 3 4 4 (100%) Combined sites 86 23 (26.7%) <.001 1 52 2 (3.8%) 2 18 6 (33.3%) 3 16 15 (93.8%)